JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espensen, E. H.
Right arrow Articles by Armstrong, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espensen, E. H.
Right arrow Articles by Armstrong, D. G.
Journal of the American Podiatric Medical Association Volume 92 Number 7 395-397 2002
Copyright © 2002 American Podiatric Medical Association

Use of Subatmospheric (VAC) Therapy to Improve Bioengineered Tissue Grafting in Diabetic Foot Wounds

Eric H. Espensen, DPM*, Brent P. Nixon, DPM{dagger}, Lawrence A. Lavery, DPM, MPH{ddagger} and David G. Armstrong, DPM§

* Attending Physician, Diabetic Foot Center, Providence St Joseph Medical Center, Burbank, CA.
{dagger} Chief, Department of Surgery, Podiatry Section, Southern Arizona Veterans Affairs Medical Center, Tucson.
{ddagger} Associate Professor, Department of Orthopaedics, Loyola University, Chicago, IL.
§ Director of Research and Education, Department of Surgery, Podiatry Section, Southern Arizona Veterans Affairs Medical Center, Tucson; Visiting Senior Lecturer of Medicine, Department of Medicine, Manchester Royal Infirmary, Manchester, England. Mailing address: Department of Surgery, Podiatry Section, Southern Arizona Veterans Affairs Medical Center, 3601 S Sixth Ave, Tucson, AZ 85723.

Abstract

The use of bioengineered tissue and topical subatmospheric pressure therapy have both been widely accepted as adjunctive therapies for the treatment of noninfected, nonischemic diabetic foot wounds. This article describes a temporally overlapping method of care that includes a period of simultaneous application of bioengineered tissue (Apligraf, Novartis Pharmaceuticals Corp, East Hanover, New Jersey) and subatmospheric pressure therapy delivered through the VAC (Vacuum Assisted Closure) system (KCI, Inc, San Antonio, Texas). Future descriptive and analytic works may test the hypothesis that combined therapies used at different and often overlapping periods during the wound-healing cycle may be more effective than a single modality. (J Am Podiatr Med Assoc 92(7): 395-397, 2002)




This article has been cited by other articles:


Home page
 Arch SurgHome page
W. S. Helton, P. M. Fisichella, R. Berger, S. Horgan, N. J. Espat, and H. Abcarian
Short-term Outcomes With Small Intestinal Submucosa for Ventral Abdominal Hernia
Arch Surg, June 1, 2005; 140(6): 549 - 562.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Podiatr. Med. Assoc.Home page
B. A. Lipsky, A. R. Berendt, H. G. Deery, J. M. Embil, W. S. Joseph, A. W. Karchmer, J. L. LeFrock, D. P. Lew, J. T. Mader, C. Norden, et al.
Diagnosis and Treatment of Diabetic Foot Infections
J Am Podiatr Med Assoc, March 1, 2005; 95(2): 183 - 210.
[Full Text] [PDF]

Home page
 INT J LOW EXTREM WOUNDSHome page
N. Petrie, M. Potter, and P. Banwell
The Management of Lower Extremity Wounds Using Topical Negative Pressure
International Journal of Lower Extremity Wounds, December 1, 2003; 2(4): 198 - 206.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Podiatric Medical Association.